0 likes | 2 Views
Gemtuzumab Ozogamicin or Gem-O, stands as a beacon of innovation in the fight against cancer. This groundbreaking antibody-drug conjugate delivers a dual blow to cancer cells, combining the precision of targeted therapy with the potency of chemotherapy. By homing in on CD33, a protein abundantly expressed in certain types of leukemia cells, Gemtuzumab Ozogamicin injection selectively seeks out and destroys malignant cells while sparing healthy tissue, minimizing adverse effects and maximizing efficacy.<br>
E N D